Nivolumab in Combination With Ipilimumab (Part 1); Nivolumab Plus Ipilimumab in Combination With Chemotherapy (Part 2) as First Line Therapy in Stage IV Non-Small Cell Lung Cancer
Clinical trial NCT02659059 · COMPLETED
Trial details
- NCT number
- NCT02659059
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-15
- Primary completion
- 2018-06-22
- Enrollment
- 324
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.